Associated Papers
Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools.
Garcia-Prieto CA et al.
Bioinformatics (oxford, England), 2022
35512388 (PubMed )
Supplement: btac306_supplementary_data.zip › Supplementary_files.zip › Supplementary_files › Supplementary_file_7.xlsx › Sheet1
AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine.
El Ahanidi H et al.
The Pan African Medical Journal, 2022
Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity.
Yi KH et al.
Oncotarget, 2016
Select a paper to view details